(Q24247212)

1

0 references

A Gross

2

0 references

T Haines

3

0 references

K Trinh

4

0 references

CH Goldsmith

5

0 references

P Aker

Cochrane Database of Systematic Reviews

6

0 references

publication date

19 April 2004

0 references

published in

0 references

cites work

Lack of effect of intraarticular corticosteroids for chronic pain in the cervical zygapophyseal joints

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The efficacy and safety of eperisone in patients with cervical spondylosis: results of a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Analgesic effectiveness of subcutaneous carbon-dioxide insufflations as an adjunct treatment in patients with non-specific neck or low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Treatment of myofascial pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Randomised clinical trial of manipulative therapy and physiotherapy for persistent back and neck complaints: results of one year follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Cervical epidural steroid injection for cervicobrachialgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Greater occipital nerve blockade in migraine, tension-type headache and cervicogenic headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

A comparative study of diazepam and acupuncture in patients with osteoarthritis pain: a placebo controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The effect of tolmetin on the chronic pain and decreased functional capacity associated with degenerative joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Possible mechanisms of action of nitric oxide synthase inhibitors in chronic tension-type headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Comparative local anaesthetic blocks in the diagnosis of cervical zygapophysial joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Botulinum toxin treatment in spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Chronic cervical zygapophysial joint pain after whiplash. A placebo-controlled prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Clinical trial on the efficacy and safety of different diclofenac formulations: multiple-unit formulations compared to enteric coated tablets in patients with activated osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Pharmacokinetics, safety, and tolerability of BAY 12-9566 and nonsteroidal anti-inflammatory agents (naproxen, ibuprofen) during coadministration in patients with osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Double-blind study of botulinum toxin in spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Tramadol versus hydrocodone-acetaminophen in acute musculoskeletal pain: a randomized, double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Conservative management of mechanical neck pain: systematic overview and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Management of neck pain: a primary care approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The prevalence of pain in a general population. The results of a postal survey in a county of Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Cyclobenzaprine and back pain: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Effect of eliminating compensation for pain and suffering on the outcome of insurance claims for whiplash injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Assessing inter-rater reliability for rating scales: resolving some basic issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Risk factors for neck pain: a longitudinal study in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The Saskatchewan Health and Back Pain Survey. The prevalence of neck pain and related disability in Saskatchewan adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The treatment of neck and low back pain: who seeks care? who goes where?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Power and sample size calculations. A review and computer program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Manual therapy for mechanical neck disorders: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Opioid therapy for chronic noncancer back pain. A randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Disc degeneration. Its frequency and relationship to symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Relationship between early somatic, radiological, cognitive and psychosocial findings and outcome during a one-year follow-up in 117 patients suffering from common whiplash

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Physician perceptions of the value of physical modalities in the treatment of musculoskeletal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The effect of antidepressant treatment on chronic back pain: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Cervicogenic headache: diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Updated method guidelines for systematic reviews in the cochrane collaboration back review group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Wirksamkeit und Verträglichkeit eines standardisierten Weidenrindenextraktes bei Arthrose-Patienten: Randomisierte, Placebo-kontrollierte Doppelblindstudie

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The Factors Associated With Neck Pain and Its Related Disability in the Saskatchewan Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

The Effectiveness of Manual Therapy, Physiotherapy, and Treatment by the General Practitioner for Nonspecific Back and Neck Complaints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

Physical therapy and adjunctive botulinum toxin type A in the treatment of cervical headache: a double-blind, randomised, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

DYSBOT: A single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A—Dysport and Botox—assuming a ratio of 4:1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

DIAZEPAM, MEPROBAMATE, AND PLACEBO IN MUSCULOSKELETAL DISORDERS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Comparative study of high bio-availability glaphenine and paracetamol in cervical and lumbar arthrosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

A multicenter, randomized, controlled trial to evaluate the safety profile, tolerability, and efficacy of rofecoxib in advanced elderly patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

[Effects of Harpagophytum procumbens LI 174 (devil's claw) on sensory, motor und vascular muscle reagibility in the treatment of unspecific back pain]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Botulinum toxin in the treatment of myofascial pain syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Chronic spinal pain syndromes: a clinical pilot trial comparing acupuncture, a nonsteroidal anti-inflammatory drug, and spinal manipulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Botulinum toxin A for the treatment of chronic neck pain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Amitriptyline Reduces Myofascial Tenderness in Patients with Chronic Tension-Type Headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Effects of acupuncture, cervical manipulation and NSAID therapy on dizziness and impaired head repositioning of suspected cervical origin: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Lidocaine injection versus dry needling to myofascial trigger point. The importance of the local twitch response.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

False-positive rates of cervical zygapophysial joint blocks.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Failure of fixed-dose, fixed muscle injection of botulinum toxin in torticollis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Intracutaneous sterile water injections do not relieve pain in cervicogenic headache

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Evaluation of the efficacy and acceptability to patients of a physiotherapist working in a health centre

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Double-blind crossover study of nabumetone versus naproxen in the treatment of osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Amtolmetin guacyl versus piroxicam in patients with osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021

Prevalence and occupational associations of neck pain in the British population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000319.PUB3

7 January 2021